Elston quickly got EyePoint Pharmaceuticals on right path


Before George Elston joined EyePoint late in 2019, securing investors in the biopharmaceutical industry was a challenge.

Previous Ellis had led Flywire through major milestones
Next ALS biotech Amylyx Pharmaceuticals has grown with CFO Frates’ help